On the deal, Linklaters is advising Rio Tinto while Gibson, Dunn & Crutcher and Davis Polk & Wardwell are advising Arcadium Lithium. Rio Tinto and Arcadium...
You must be a Standard 1 Year member to access this content.
Aird & Berlis acted for Biomind on the transaction. Biomind Labs Inc. (formerly Crosswinds Holdings Inc.), in connection with the Reverse Takeover of Crosswinds Holdings, completed a private placement...
You must be a Standard 1 Year member to access this content.
Aird & Berlis acted for Biomind on the transaction. On July 23, 2021, Biomind Labs Inc. (formerly Crosswinds Holdings Inc.) completed a plan of merger under the...
You must be a Standard 1 Year member to access this content.
Aird & Berlis acted for Galane Gold Ltd. in connection with the transaction. On May 19, 2021, Galane Gold Ltd. (TSX-V: GG; OTCQB: GGGOF), through a...
You must be a Standard 1 Year member to access this content.
Aird & Berlis represented Maritime Resources. Maritime Resources Corp. closed a strategic investment by Tembo Capital. Tembo has acquired 30,770,000 Common Shares, at a price of...
You must be a Standard 1 Year member to access this content.
Aird & Berlis represented Maritime Resources. Maritime Resources Corp. closed an asset purchase agreement with two subsidiaries of Rambler Metals and Mining PLC, namely Rambler Metals...
You must be a Standard 1 Year member to access this content.
Aird & Berlis LLP represented Allied on the offering. Allied Properties Real Estate Investment Trust completed a $600 million debt offering of 1.726% series H senior unsecured...
You must be a Standard 1 Year member to access this content.
Aird & Berlis LLP represented Harborside on the offering. Harborside Inc. completed a brokered private placement offering of units for aggregate gross proceeds of approximately $35...
You must be a Standard 1 Year member to access this content.
Aird & Berlis represented the PsyBio Therapeutics, Inc. PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) completed a reverse takeover of PsyBio Therapeutics, Inc., a biotechnology company developing...
You must be a Standard 1 Year member to access this content.
